en
Scientific article
English

Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort Study

CollaboratorsAubert, V; Battegay, M; Bernasconi, E; Böni, J; Braun, D L; Bucher, H C; Burton-Jeangros, Claudineorcid; Cavassini, M; Dollenmaier, G; Egger, M; Elzi, L; Fehr, J; Fellay, J; Furrer, H; Fux, C A; Gorgievski, M; Günthard, H; Haerry, D; Hasse, B; Hirsch, H H; Hoffmann, M; Hösli, I; Kahlert, C; Kaiser, L; Keiser, Oliviaorcid; Klimkait, T; Kouyos, R; Martinetti, G; Martinez De Tejada Weber, Begona; Marzolini, C; Metzner, K; Müller, N; Nadal, D; Nicca, D; Pantaleo, G; Rauch, A; Rudin, C; Schöni-Affolter, F; Schmid, P; Speck, R; Stöckle, M; Trkola, A; Vernazza, P; Yerly Ferrillo, Sabine
Published inClinical Infectious Diseases, vol. 70, no. 5, p. 884-889
Publication date2020
Abstract

Coronary artery disease (CAD) events have been associated with certain antiretroviral therapy (ART) agents. In contrast, the influence of ART on subclinical atherosclerosis is not clear. The study objective was to assess the association between individual ART agents and the prevalence and extent of subclinical CAD.

Keywords
  • HIV
  • Antiretroviral therapy
  • Subclinical coronary artery disease
Research group
Citation (ISO format)
KOVARI, Helen et al. Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort Study. In: Clinical Infectious Diseases, 2020, vol. 70, n° 5, p. 884–889. doi: 10.1093/cid/ciz283
Main files (1)
Article (Published version)
accessLevelRestricted
Secondary files (1)
Identifiers
ISSN of the journal1058-4838
165views
0downloads

Technical informations

Creation10/30/2020 8:13:00 PM
First validation10/30/2020 8:13:00 PM
Update time03/16/2023 12:55:31 AM
Status update03/16/2023 12:55:27 AM
Last indexation05/06/2024 7:49:21 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack